← Product Code [DKK](/submissions/CH/subpart-c%E2%80%94clinical-laboratory-instruments/DKK) · K812919

# MULTI-GRAM DEVELOPING TANK R-12 & R-3 (K812919)

_Marion Laboratories, Inc. · DKK · Nov 2, 1981 · Clinical Chemistry · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/TX/subpart-c%E2%80%94clinical-laboratory-instruments/DKK/K812919

## Device Facts

- **Applicant:** Marion Laboratories, Inc.
- **Product Code:** [DKK](/submissions/CH/subpart-c%E2%80%94clinical-laboratory-instruments/DKK.md)
- **Decision Date:** Nov 2, 1981
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.2270
- **Device Class:** Class 1
- **Review Panel:** Clinical Chemistry

## Regulatory Identification

A thin-layer chromatography (TLC) system for clinical use is a device intended to separate one or more drugs or compounds from a mixture. The mixture of compounds is absorbed onto a stationary phase or thin layer of inert material (e.g., cellulose, alumina, etc.) and eluted off by a moving solvent (moving phase) until equilibrium occurs between the two phases.

---

**Source:** [https://fda.innolitics.com/submissions/TX/subpart-c%E2%80%94clinical-laboratory-instruments/DKK/K812919](https://fda.innolitics.com/submissions/TX/subpart-c%E2%80%94clinical-laboratory-instruments/DKK/K812919)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
